PeptiDream Inc. (TYO:4587)
Japan flag Japan · Delayed Price · Currency is JPY
1,090.00
-32.00 (-2.85%)
Nov 18, 2026, 10:40 AM JST

PeptiDream Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
20,48418,52146,67628,71226,8529,366
Revenue Growth
14.25%-60.32%62.57%6.93%186.70%-19.79%
Gross Profit
9,6477,52234,50317,21818,1137,008
Operating Income
-3,822-4,95821,0226,8118,8424,418
Net Income
-2,894-3,74915,0143,0357,5543,606
Earnings Per Share
-22.46-28.99115.6823.3858.1427.78
EPS Growth
--394.78%-59.79%109.29%-18.91%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Unallocated Adjustments
-1,089-1,151-740.69-86.96-27.18-
Radioactive Pharmaceutical Business
17,12216,87916,10416,09611,474-
Drug Discovery and Development Business
4,4512,79331,31312,70315,4069,366
Total
20,48418,52146,67728,71226,8529,366

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
20,28528,68248,11719,5075,24711,747
Total Debt
15,03617,70620,35122,79821,675-
Net Cash (Debt)
5,24910,97627,766-3,291-16,42811,747
Net Cash Growth
-59.12%-60.47%---64.30%
Net Cash Per Share
40.7284.88213.93-25.35-126.4390.48

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4,402-13,27623,84412,420-826,655
Capital Expenditures
-1,364-1,643-2,077-1,212-3,721-1,186
Free Cash Flow
-5,766-14,91921,76711,208-3,8035,469
Free Cash Flow Growth
--94.21%--372.74%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
47.09%40.61%73.92%59.97%67.45%74.82%
Operating Margin
-18.66%-26.77%45.04%23.72%32.93%47.17%
Pretax Margin
-20.14%-28.68%44.75%15.16%24.78%51.50%
Profit Margin
-14.13%-20.24%32.17%10.57%28.13%38.51%
FCF Margin
-28.15%-80.55%46.63%39.04%-14.16%58.39%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--22.8363.4835.7091.62
Forward PE
20.2114.5228.7622.6037.93-
P/FCF Ratio
--15.7517.19-60.42
PS Ratio
7.0011.567.346.7110.0435.28